title: Candidal thrombophlebitis of central veins: case report and review.
abstract: Although candidemia and central catheter septic thrombosis is quite common, central veins thrombophlebitis caused by Candida spp. is a rarely reported complication in critically ill patients. Here we report a case of thrombophlebitis of the right internal jugular and subclavian veins due to Candida albicans which occurred in a patient admitted in the intensive care unit for major trauma. The individual was eventually cured after prolonged course of antifungal therapy. We also review 24 additional cases of Candida induced central veins thrombophlebitis reported since 1978. A central vein catheter was in place in all 25 patients with 21 (84%) being admitted in an intensive care unit, 22 (88%) were receiving total parenteral nutrition and 23 (92%) undergoing a course of antibiotic therapy. Overall mortality was 16%, including two patients who received no therapy and died. In the group of patients receiving only medical therapy, the mortality rate was 13%, while no deaths were observed among those treated with combined medical and surgical therapy. Literature data suggest that Candida caused central veins thrombophlebitis is a rare and probably underdiagnosed infectious complication of the critically ill patient. Despite the dramatic presentation with persistent candidemia, mortality is low even with a conservative medical approach with prolonged fungicidal therapy through the use of amphotericin B or echinocandins. Thus, the decision for a combined surgical debridement should be assessed for each patient.
authors: Department of Emergency Medicine, San Giovanni-Addolorata Hospital, Rome, Italy.
authors: Roberta
authors: R
authors: Caccese
authors: Paolo
authors: P
authors: Carfagna
authors: Norma
authors: N
authors: Pistilli
authors: Anna Paola
authors: AP
authors: Massetti
authors: Marco
authors: M
authors: Falcone
authors: Mario
authors: M
authors: Venditti
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage; D002176:Candida albicans / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D006801:Humans; D007362:Intensive Care Units; D007601:Jugular Veins / Q000382:microbiology / Q000473:pathology; D008297:Male; D013350:Subclavian Vein / Q000382:microbiology / Q000473:pathology; D016019:Survival Analysis; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D016896:Treatment Outcome; D014947:Wounds and Injuries / Q000150:complications
chemical_list: D000935:Antifungal Agents